RxDoctor Payments Data

James Zimmerman, MD

Vascular Surgery · Redwood City, CANPI 1093729121

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $50,950 of the $74,365 with a category attached, or 68.5%. 14 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 57.3% of the total. Reporting peaked in 2019 at $46,558 and has fallen 96.0% since, to $1,853 in 2025. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,365in general payments, 2019–2025

Across 168 payments — averaging $442.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$43K
  • Medtronic$14K
  • Philips North America LLC$9K
  • Penumbra, Inc.$5K
  • Provisio Medical, Inc.$2K
  • Silk Road Medical, Inc.$1K
  • plus $1K from 8 others

What the payments were for

  • Consulting fees$2,7504%
  • Speaking & faculty fees$50,95069%
  • Travel & lodging$8,18711%
  • Food & beverage$12,47917%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,365 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California

Medicare billing

Part B allowed, 2024
$388,446
Medicare patients
548
Services billed
1,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate58$1,378
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen114$793
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$38

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Redwood City

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →